check_circleStudy Completed
Hemophilia A
Bayer Identifier:
14344
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
EffeKt Taiwan- Efficacy and Safety of long-term treatment with KOGENATE® FS in Taiwan
Trial purpose
The aim of this international prospective post-marketing surveillance study is to obtain data on treatment procedures, long-term safety and efficacy and patient acceptance of KOGENATE Bayer/FS in treatment of patients with haemophilia A under daily-life treatment conditions.
Key Participants Requirements
Sex
MaleAge
0 - N/ATrial summary
Enrollment Goal
82Trial Dates
April 2009 - December 2011Phase
N/ACould I Receive a placebo
NoProducts
Kogenate FS (Recombinant Factor VIII, BAY14-2222)Accepts Healthy Volunteer
NoWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Many Locations, Taiwan |
Primary Outcome
- Efficacy and Safety of Kogenate FSdate_rangeTime Frame:After 12 months and after 24 monthsenhanced_encryptionYesSafety Issue:
Trial design
Trial Type
ObservationalIntervention Type
Biological/VaccineTrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A